Neuroimaging of posttraumatic stress disorder in adults and youth: progress over the last decade on three leading questions of the field

Cecilia A. Hinojosa,Grace C. George,Ziv Ben-Zion
DOI: https://doi.org/10.1038/s41380-024-02558-w
IF: 11
2024-04-18
Molecular Psychiatry
Abstract:Almost three decades have passed since the first posttraumatic stress disorder (PTSD) neuroimaging study was published. Since then, the field of clinical neuroscience has made advancements in understanding the neural correlates of PTSD to create more efficacious treatment strategies. While gold-standard psychotherapy options are available, many patients do not respond to them, prematurely drop out, or never initiate treatment. Therefore, elucidating the neurobiological mechanisms that define the disorder can help guide clinician decision-making and develop individualized mechanisms-based treatment options. To this end, this narrative review highlights progress made in the last decade in adult and youth samples on three outstanding questions in PTSD research: (1) Which neural alterations serve as predisposing (pre-exposure) risk factors for PTSD development, and which are acquired (post-exposure) alterations? (2) Which neural alterations can predict treatment outcomes and define clinical improvement? and (3) Can neuroimaging measures be used to define brain-based biotypes of PTSD? While the studies highlighted in this review have made progress in answering the three questions, the field still has much to do before implementing these findings into clinical practice. Overall, to better answer these questions, we suggest that future neuroimaging studies of PTSD should (A) utilize prospective longitudinal designs, collecting brain measures before experiencing trauma and at multiple follow-up time points post-trauma, taking advantage of multi-site collaborations/consortiums; (B) collect two scans to explore changes in brain alterations from pre-to-post treatment and compare changes in neural activation between treatment groups, including longitudinal follow up assessments; and (C) replicate brain-based biotypes of PTSD. By synthesizing recent findings, this narrative review will pave the way for personalized treatment approaches grounded in neurobiological evidence.
biochemistry & molecular biology,neurosciences,psychiatry
What problem does this paper attempt to address?
The paper attempts to address three main issues: 1. **Which neural changes serve as a priori risk factors for the development of post-traumatic stress disorder (PTSD), and which are acquired after trauma exposure?** - The paper explores whether pre-existing neural structural or functional changes indicate a higher likelihood of developing PTSD, and what new neural changes appear after the traumatic event. 2. **Which neural changes can predict treatment outcomes and define clinical improvement?** - The study investigates whether specific neurobiological markers can predict the efficacy of different treatment methods and whether changes in these markers are associated with clinical symptom improvement. 3. **Can neuroimaging measurements be used to define brain-based biological subtypes of PTSD?** - The paper examines whether neuroimaging techniques can identify different subtypes of PTSD, whether these subtypes have unique neurobiological characteristics, and how this can aid in the development of individualized treatment plans. By reviewing the research progress of the past 10 years, the paper aims to promote the development of personalized treatment strategies based on neurobiological evidence. To better answer these questions, future research needs to adopt prospective longitudinal designs, collect brain data before and after trauma, and conduct multi-site collaborative studies to validate brain-based biological subtypes of PTSD.